Streetbeat News

Marketing

SBM

Sirona Biochem Corp. announced the publication of a study on their TFC-1326 compound in the Journal of Cosmetic Dermatology, highlighting its potential impact in the field of cosmetic dermatology.

Portfolio Pulse from

November 20, 2024 | 9:45 pm

APTV

Aptiv PLC, a global technology company, will present at the UBS Global Industrials and Transportation Conference on December 4. The presentation will be webcasted on their Investor Relations website.

Portfolio Pulse from

November 20, 2024 | 9:45 pm

ECVT

Ecovyst Inc. (NYSE: ECVT) announced that its Vice President of Finance & Treasurer, Nate Connor, will present at the Bank of America 2024 Leveraged Finance Conference.

Portfolio Pulse from

November 20, 2024 | 9:45 pm

MAT

Mattel, Inc. will participate in a fireside chat at the Morgan Stanley Global Consumer & Retail Conference on December 4, 2024. The event will feature Mattel's CEO and CFO and will be webcast on the company's Investor Relations website.

Portfolio Pulse from

November 20, 2024 | 9:45 pm

PEN

Penumbra, Inc. will present at the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024.

Portfolio Pulse from

November 20, 2024 | 9:45 pm

SIBN

SI-BONE, Inc. (Nasdaq: SIBN) will present at the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024. The company will host a fireside chat, providing insights into its operations and strategies.

Portfolio Pulse from

November 20, 2024 | 9:30 pm

CSCO

Cisco Systems, Inc. participated in the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference, with Scott Herren, the Executive Vice President and CFO, representing the company.

Portfolio Pulse from

November 20, 2024 | 9:30 pm

ENFN

Enfusion, Inc. (NYSE: ENFN), a SaaS provider for investment managers, will have its CFO and COO present at the Wells Fargo 8th Annual TMT Summit and the UBS Global Technology and AI Conference in December 2024.

Portfolio Pulse from

November 20, 2024 | 9:30 pm

CRBU

Caribou Biosciences, a clinical-stage CRISPR genome-editing biopharmaceutical company, announced that its CEO, Rachel Haurwitz, will participate in upcoming investor conferences.

Portfolio Pulse from

November 20, 2024 | 9:15 pm

NYXH

Nyxoah is set to participate in the Piper Sandler 36th Annual Healthcare Conference, which could provide the company with increased visibility and networking opportunities in the healthcare sector.

Portfolio Pulse from

November 20, 2024 | 9:15 pm